The Home Office Hangover What has lockdown done to our eyes?
As the COVID -19 lockdown restrictions continue to ease, clinicians are reporting an increase in the signs and symptoms of dry eye. Working from home has become the new normal for many and the increased use of digital media for communication is taking its toll on the tear film.
This presentation will consider the increase in symptoms of dry eye and blepharitis that clinicians are hearing since the start of the lockdown and discuss the possible reasons. It will consider the link between blepharitis and dry eye and encourage practitioners to proactively question patients for symptoms in addition to looking for signs. It will include a review of currently available management options, including new novel formulations so that we can continue to offer the best advice and recommendations to patients in order to effectively manage blepharitis and dry eye.
CPD Points: 1
CPDpoints.com credits: 1
Expiry Date: 31/12/2024
Also accepted by
A Personal Perspective of Dry Eye
Peter Charlesworth is an optometrist who suffers from dry eyes. In this recorded webinar, he'll take you through his journey from someone who manages patients' dry eyes to someone who manages their own dry eye.
The Lowdown on Demodex
Demodex is one of the most common, but often overlooked, causes of blepharitis and ocular surface inflammation, being associated with between 29% and 74% of all cases of blepharitis. This article will review demodex, its prevalence, its diagnosis and its treatment.
Dry Eye Diagnosis and Treatment
Dry eye disease (DED) affects hundreds of millions of people throughout the world and is one of the most frequent causes of patient visits to eye care practitioners. Exacerbated by modern lifestyles, symptoms of DED vary widely from mild dryness to severe pain and blurred vision. A better understanding of this multifactorial disease has led to new and better treatments, many of which are in the realm of optometric and contact lens practice.